跳至主要内容
临床试验/NCT07569094
NCT07569094尚未招募不适用

Research Plan for Early Disease Screening Biomarkers in Healthy Individuals

Zhonghao Fang1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2026年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
300
试验地点
1
主要终点
Blood routine test

研究概览

简要总结

The establishment of reference intervals for biomarkers in healthy populations relies on large-scale, standardized cohort data. However, current baseline data for hematology, liver and kidney function, and multi-omics (genomics, transcriptomics, proteomics, and metabolomics) in Chinese healthy populations are constrained by significant regional disparities and insufficient sample sizes, limiting the development of early disease screening markers. To address these challenges, this study aims to: (1) establish a comprehensive database for hematology and liver/kidney function indicators; (2) construct a multi-omics database using blood and sputum samples; and (3) explore the correlations among multi-omics indicators and their associations with demographic characteristics.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age: 18 - 65 years old, gender not restricted;
  • No clear history of chronic diseases (hypertension, diabetes, cardiovascular and cerebrovascular diseases, chronic liver and kidney diseases, tumors, etc.);
  • No infection history in the past 3 months (fever, cough, sore throat, etc.);
  • No use of antibiotics, hormones, immunosuppressants, etc. within the past 1 month;
  • Voluntarily sign the informed consent form and cooperate to complete the follow-up.

排除标准

  • Abnormal laboratory indicators (ALT/AST > 2 times the upper limit of normal value, Cr > upper limit of normal value, main indicators of blood routine test are abnormal and have clinical significance);
  • Pregnant or lactating women;
  • Recent (within 3 months) history of surgery, trauma or blood transfusion;
  • Mental illness or cognitive impairment that makes it impossible to cooperate with the research.

研究组 & 干预措施

Health

healthy populations

结局指标

主要结局

Blood routine test

时间窗: At the time of enrollment

次要结局

  • Liver function(At the time of enrollment)
  • renal function(At the time of enrollment)

研究者

发起方
Zhonghao Fang
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Zhonghao Fang

Doctor

Guangzhou Medical University

研究点 (1)

Loading locations...

相似试验